GEHC SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 28, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 29, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 29, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 30, 2025

News

TYPE

HEADLINE

FILED AT

8-K

GE HealthCare Technologies Announces Resignation of Chief Science and Technology Officer Taha Kass-Hout

Nov 5, 2026

8-K

GE HealthCare Technologies Inc. Announces Third Quarter 2026 Results and Officer Resignation

Oct 28, 2026

8-K

GE HealthCare Technologies Inc. Appoints Pascal Desroches to Board of Directors

Sep 22, 2026

8-K

GE HealthCare Technologies Inc. Appoints William K. Grogan as Chief Financial Officer

Aug 18, 2026

8-K

GE HealthCare Announces Strategic Realignment of Reportable Segments

Jul 29, 2026

8-K

GE HealthCare Technologies Inc. Announces Second Quarter 2026 Financial Results

Jul 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Dec 2, 2025

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Dec 1, 2025

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Jun 5, 2025

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Jun 3, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 13,281,302 | Share price: $88.20 | Offering amount: $1,171,410,836.00

Nov 8, 2024

424B3

Up to 61,581,302 Shares

Sep 13, 2024

Registrations

TYPE

HEADLINE

FILED AT

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 1, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jun 3, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 7, 2024

FWP

Secondary Offering of 10,000,000 Shares

Sep 12, 2024

FWP

Registration

Aug 7, 2024

S-3ASR

Registration

Jun 28, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 19, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 19, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 10, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 10, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 4, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 4, 2024

Ownerships

TYPE

HEADLINE

FILED AT

144

Form 144 - Report of proposed sale of securities

Nov 4, 2026

Grogan William K (Reporting)

Sep 16, 2026

Grogan William K (Reporting)

Sep 16, 2026

Rackliffe Philip (Reporting)

Sep 4, 2026

O'Neill Kevin Michael (Reporting)

Sep 4, 2026

Newcomb George A. (Reporting)

Sep 4, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 29, 2026

Form SD - Specialized disclosure report

May 29, 2025

Form SD - Specialized disclosure report

May 30, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 3, 2023

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 8, 2023

CORRESP

Form CORRESP - Correspondence

Jun 5, 2023

GE HealthCare Technologies Inc. GEHC · SEC Filings